Show simple item record

dc.contributor.authorHannon, E
dc.contributor.authorSpiers, Helen
dc.contributor.authorViana, J
dc.contributor.authorPidsley, R
dc.contributor.authorBurrage, J
dc.contributor.authorMurphy, TM
dc.contributor.authorTroakes, C
dc.contributor.authorTurecki, Gustavo
dc.contributor.authorO'Donovan, Michael C.
dc.contributor.authorSchalkwyk, Leonard
dc.contributor.authorBray, Nicholas J.
dc.contributor.authorMill, J
dc.date.accessioned2016-01-13T13:43:11Z
dc.date.issued2015-11-30
dc.description.abstractWe characterized DNA methylation quantitative trait loci (mQTLs) in a large collection (n = 166) of human fetal brain samples spanning 56-166 d post-conception, identifying >16,000 fetal brain mQTLs. Fetal brain mQTLs were primarily cis-acting, enriched in regulatory chromatin domains and transcription factor binding sites, and showed substantial overlap with genetic variants that were also associated with gene expression in the brain. Using tissue from three distinct regions of the adult brain (prefrontal cortex, striatum and cerebellum), we found that most fetal brain mQTLs were developmentally stable, although a subset was characterized by fetal-specific effects. Fetal brain mQTLs were enriched amongst risk loci identified in a recent large-scale genome-wide association study (GWAS) of schizophrenia, a severe psychiatric disorder with a hypothesized neurodevelopmental component. Finally, we found that mQTLs can be used to refine GWAS loci through the identification of discrete sites of variable fetal brain methylation associated with schizophrenia risk variants.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipUS National Institutes of Healthen_GB
dc.description.sponsorshipMRC/Wellcome Trusten_GB
dc.identifier.citationVol. 19, pp. 48 - 54en_GB
dc.identifier.doi10.1038/nn.4182
dc.identifier.grantnumberMR/K013807/1en_GB
dc.identifier.grantnumberMR/L010674/1en_GB
dc.identifier.grantnumberAG036039en_GB
dc.identifier.grantnumber099175/Z/12/Zen_GB
dc.identifier.urihttp://hdl.handle.net/10871/19226
dc.language.isoenen_GB
dc.publisherNature Publishing Groupen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/26619357en_GB
dc.rights.embargoreasonPublisher policyen_GB
dc.subjectDNA methylationen_GB
dc.subjectEpigenomicsen_GB
dc.subjectNeurodevelopmental disordersen_GB
dc.subjectSchizophreniaen_GB
dc.titleMethylation QTLs in the developing brain and their enrichment in schizophrenia risk locien_GB
dc.typeArticleen_GB
dc.identifier.issn1097-6256
exeter.place-of-publicationUnited States
dc.identifier.eissn1546-1726
dc.identifier.journalNature Neuroscienceen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record